🚨 URGENT: NC Medicaid Coverage for AOMs at Risk!

 📌 What’s happening?
Provision 133700, tucked into the current North Carolina House budget proposal, would eliminate Medicaid coverage for evidence-based anti-obesity medications, including widely used GLP-1 therapies.

📉 What this means:
This isn’t about cosmetic weight loss— it’s about treating obesity as a serious medical disease. These medications help manage chronic conditions like heart disease, diabetes, and kidney failure, and they're proven to reduce heart attacks, strokes, and long-term healthcare costs.

🧠 Why it matters:
Over 1 in 3 North Carolinians live with obesity.

These medications are standard of care— not luxury drugs.

Cutting coverage will hit low-income residents the hardest, worsening health disparities.

Studies show that GLP-1 therapies can lead to a >40% reduction in major cardiac events and 7% lower medical costs by year two (AON Study, 2025).

🔗 Link to Article:
https://lnkd.in/ebSRBV7C

🏛️ CALL TO ACTION
We urge the North Carolina General Assembly to strike Provision 133700 from the budget before this week’s vote.

💬 NC Residents: Email or call your House representative and tell them to protect Medicaid access to anti-obesity care.

📄 Find your NC House Member here:
👉🏻 https://lnkd.in/ey3gKsKY

📣 MEDIA, PLEASE SHARE:
Help inform the public before it’s too late. This issue affects real families, healthcare workers, and our state’s future health costs.

📢 Contact:
North Carolina Obesity Society
📧 info@ncobesitysociety.org
🌐 ncobesitysociety.org

hashtag#NCMedicaid hashtag#GLP1 hashtag#NCHealth hashtag#ObesityCare hashtag#ProtectMedicaid hashtag#NCGA hashtag#NorthCarolina hashtag#PublicHealth

GLP-1s can help employers lower medical costs in 2 years, new study finds
cnbc.com